Journal of studies on alcohol and drugs · 2025
Product Characteristics, Warnings, and Marketing Appeals Conveyed on Delta-8 THC Product Packaging in the United States and Canada.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Robichaud Meagan O, Spillane Torra E, Kennedy Ryan David, Hammond David
Аннотация
OBJECTIVE: Delta-8 tetrahydrocannabinol (delta-8 THC) cannabis products proliferated in the United States following the 2018 Farm Bill and are marketed in Canada. This study assessed the characteristics and marketing appeals displayed on the exterior packaging of a sample of U.S. and Canadian delta-8 THC products.
METHOD: Delta-8 THC packaging photos were obtained from U.S. and Canadian respondents from the 2021 and 2022 International Cannabis Policy Study. A content analysis assessed cannabinoid content labels, presence and placement of health warnings, and marketing appeals (e.g., "hemp" descriptors, cartoons). Packages were double-coded.
RESULTS: The sample (N = 140 products) included ingestibles (43.6%, n = 61); vapes (37.9%, n = 53); dried flower (7.9%, n = 11); oral liquids (6.4%, n = 9); and pre-rolls, topicals, and concentrates (1.4%, n = 2 each). Fifteen percent (n = 21) listed cannabinoids in addition to delta-8 THC; 6.4% (n = 9) listed other intoxicating cannabinoids (delta-9 THC, delta-10 THC, and/or hexahydrocannabinol). Intoxicating cannabinoid content (including delta-8 THC) per piece and per pack was specified for 82% (n = 50/61) and 73.8% (n = 45/61) of ingestibles, respectively. A minority of vapes (17%, n = 9/53), dried flower (27.3%, n = 3/11), and oral liquids (33.3%, n = 3/9) stated their concentration. Warnings were observed on 32.9% of products (n = 46), including 11.7% (n = 16/137) of primary surfaces and 67.4% (n = 31/46) of secondary surfaces. Marketing appeals included "hemp" descriptors (43.6%, n = 61), cannabis symbols (28.6%, n = 40), referencing the legality of delta-8 THC (25.7%, n = 36), and cartoons (21.4%, n = 30).
CONCLUSIONS: Delta-8 THC products come in many forms and often lack health warnings and details about cannabinoid content. Studies assessing how delta-8 THC product packaging information impacts use patterns are needed.
METHOD: Delta-8 THC packaging photos were obtained from U.S. and Canadian respondents from the 2021 and 2022 International Cannabis Policy Study. A content analysis assessed cannabinoid content labels, presence and placement of health warnings, and marketing appeals (e.g., "hemp" descriptors, cartoons). Packages were double-coded.
RESULTS: The sample (N = 140 products) included ingestibles (43.6%, n = 61); vapes (37.9%, n = 53); dried flower (7.9%, n = 11); oral liquids (6.4%, n = 9); and pre-rolls, topicals, and concentrates (1.4%, n = 2 each). Fifteen percent (n = 21) listed cannabinoids in addition to delta-8 THC; 6.4% (n = 9) listed other intoxicating cannabinoids (delta-9 THC, delta-10 THC, and/or hexahydrocannabinol). Intoxicating cannabinoid content (including delta-8 THC) per piece and per pack was specified for 82% (n = 50/61) and 73.8% (n = 45/61) of ingestibles, respectively. A minority of vapes (17%, n = 9/53), dried flower (27.3%, n = 3/11), and oral liquids (33.3%, n = 3/9) stated their concentration. Warnings were observed on 32.9% of products (n = 46), including 11.7% (n = 16/137) of primary surfaces and 67.4% (n = 31/46) of secondary surfaces. Marketing appeals included "hemp" descriptors (43.6%, n = 61), cannabis symbols (28.6%, n = 40), referencing the legality of delta-8 THC (25.7%, n = 36), and cartoons (21.4%, n = 30).
CONCLUSIONS: Delta-8 THC products come in many forms and often lack health warnings and details about cannabinoid content. Studies assessing how delta-8 THC product packaging information impacts use patterns are needed.